(Q43882777)

English

Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

author name string

Crook JM

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Akil M

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Law BC

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Hyde TM

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kleinman JE

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Molecular Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

157-164

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Glutamate: A Neurotransmitter in Mammalian Brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

The reduced neuropil hypothesis: a circuit based model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Neuroleptics ameliorate phencyclidine-induced impairments of short-term memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Interactive effects of subanesthetic ketamine and haloperidol in healthy humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: organizational features related to cortical circuitry, function and disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Characterization of a presynaptic glutamate receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

The metabotropic glutamate receptors: structure and functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

The function of metabotropic excitatory amino acid receptors in synaptic transmission in the thalamus: Studies with novel phenylglycine antagonists☆

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Metabotropic glutamate receptor activation and blockade: their role in long-term potentiation, learning and neurotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Pharmacology and functions of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Metabotropic G-protein-coupled glutamate receptors as therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Inhibition of Cyclic AMP Formation by a Selective Metabotropic Glutamate Receptor Agonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Cytoarchitectonic Definition of Prefrontal Areas in the Normal Human Cortex: II. Variability in Locations of Areas 9 and 46 and Relationship to the Talairach Coordinate System

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

A versatile and simple method for staining nervous tissue using Giemsa dye.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Localization of glutamate receptors in dorsal horn of rat spinal cord

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

The role of glutamate receptors in antipsychotic drug action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

21 January 2018

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

7 January 2021

based on heuristic

inferred from DOI database lookup

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

7 January 2021

based on heuristic

inferred from DOI database lookup

Presynaptic NMDA receptors display physiological characteristics of homomeric complexes of NR1 subunits that contain the exon 5 insert in the N-terminal domain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabotropic glutamate receptors: electrophysiological properties and role in plasticity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabotropic glutamate receptor types 2/3 inhibit L-type calcium channels via a pertussis toxin-sensitive G-protein in cultured cerebellar granule cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

7 January 2021

based on heuristic

inferred from DOI database lookup

The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

7 January 2021

based on heuristic

inferred from DOI database lookup

The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000966

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.MP.4000966

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43882777&oldid=2206313272"